Publications by authors named "Claude Cochet"

Claim this Profile
N
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities.
Beatrice Cesana, Claude Cochet, Odile Filhol

Int J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold.
Hend Khalifa, Ahmed K ElHady, Ting Liu, Walid A M Elgaher, Odile Filhol-Cochet, Claude Cochet

Eur J Med Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
Ann Y Park, Michael Leney-Greene, Matthew Lynberg, Justin Q Gabrielski, Xijin Xu, Claude Cochet

Nat Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
Ann Y Park, Michael Leney-Greene, Matthew Lynberg, Justin Q Gabrielski, Xijin Xu, Claude Cochet

Nat Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.
Alexandre Bancet, Rita Frem, Florian Jeanneret, Angélique Mularoni, Pauline Bazelle, Claude Cochet

iScience· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma.
Irinka Séraudie, Catherine Pillet, Beatrice Cesana, Pauline Bazelle, Florian Jeanneret, Claude Cochet

Cell Death Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage.
Dzenis Koca, Irinka Séraudie, Rémy Jardillier, Claude Cochet, Odile Filhol

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of RAGE and CK2 Expressions in Human Fetal Membranes.
Karen Coste, Shaam Bruet, Caroline Chollat-Namy, Odile Filhol, Claude Cochet

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CK2β Is a Gatekeeper of Focal Adhesions Regulating Cell Spreading.
Odile Filhol, Anne-Marie Hesse, Anne-Pascale Bouin, Corinne Albigès-Rizo, Florian Jeanneret, Claude Cochet

Front Mol Biosci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction.
Sofia Giacosa, Catherine Pillet, Irinka Séraudie, Laurent Guyon, Yann Wallez, Claude Cochet

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome.
Yasser Perera, Yassel Ramos, Gabriel Padrón, Evelin Caballero, Osmany Guirola, Claude Cochet

Mol Cell Biochem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase CK2 contributes to placental development: physiological and pathological implications.
Roland Abi Nahed, Deborah Reynaud, Nicolas Lemaitre, Solene Lartigue, Caroline Roelants, Claude Cochet

J Mol Med (Berl)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.
Caroline Roelants, Catherine Pillet, Quentin Franquet, Clément Sarrazin, Nicolas Peilleron, Claude Cochet

Cancers (Basel)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.
Irina Kufareva, Benoit Bestgen, Paul Brear, Renaud Prudent, Béatrice Laudet, Claude Cochet

Sci Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.
Loïc Lionnard, Pauline Duc, Margs S Brennan, Andrew J Kueh, Martin Pal, Claude Cochet

Cell Death Differ· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.
Roelants Caroline, Giacosa Sofia, Pillet Catherine, Bussat Remi, Champelovier Pierre, Cochet Claude

Oncotarget· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.
Benoît Bestgen, Irina Kufareva, Weiguang Seetoh, Chris Abell, Rolf W Hartmann, Claude Cochet

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.
Benoît Bestgen, Isabelle Krimm, Irina Kufareva, Ahmed Ashraf Moustafa Kamal, Wei-Guang Seetoh, Claude Cochet

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.
Caroline Roelants, Sofia Giacosa, Catherine Pillet, Rémi Bussat, Pierre Champelovier, Claude Cochet

Oncotarget· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma.
Helena Polena, Julie Creuzet, Maeva Dufies, Adama Sidibé, Abir Khalil-Mgharbel, Claude Cochet

Br J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem Cell-Like Properties of CK2β-down Regulated Mammary Cells.
Eve Duchemin-Pelletier, Megghane Baulard, Elodie Spreux, Magali Prioux, Mithila Burute, Claude Cochet

Cancers (Basel)· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizers.
Marie de Bourayne, Yann Gallais, Zeina El Ali, Philippe Rousseau, Marie-Hélène Damiens, Claude Cochet

J Leukoc Biol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface.
Benoît Bestgen, Zakia Belaid-Choucair, Thierry Lomberget, Marc Le Borgne, Odile Filhol, Claude Cochet

Pharmaceuticals (Basel)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD).
Valérie Vilmont, Odile Filhol, Anne-Marie Hesse, Yohann Couté, Christophe Hue, Claude Cochet

Biochim Biophys Acta· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.
Odile Filhol, Sofia Giacosa, Yann Wallez, Claude Cochet

Cell Mol Life Sci· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis